287 related articles for article (PubMed ID: 25562667)
1. eIF4E is an adverse prognostic marker of melanoma patient survival by increasing melanoma cell invasion.
Khosravi S; Tam KJ; Ardekani GS; Martinka M; McElwee KJ; Ong CJ
J Invest Dermatol; 2015 May; 135(5):1358-1367. PubMed ID: 25562667
[TBL] [Abstract][Full Text] [Related]
2. Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.
Chen G; Cheng Y; Tang Y; Martinka M; Li G
J Invest Dermatol; 2012 Nov; 132(11):2632-41. PubMed ID: 22673729
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma.
Carter JH; Deddens JA; Spaulding NR; Lucas D; Colligan BM; Lewis TG; Hawkins E; Jones J; Pemberton JO; Douglass LE; Graff JR
Br J Cancer; 2016 Feb; 114(4):444-53. PubMed ID: 26882068
[TBL] [Abstract][Full Text] [Related]
4. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
5. Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion.
Khosravi S; Wong RP; Ardekani GS; Zhang G; Martinka M; Ong CJ; Li G
Br J Cancer; 2014 Jan; 110(2):399-408. PubMed ID: 24178756
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of cytoplasmic p27 expression in human melanoma.
Chen G; Cheng Y; Zhang Z; Martinka M; Li G
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.
Dai DL; Martinka M; Li G
J Clin Oncol; 2005 Mar; 23(7):1473-82. PubMed ID: 15735123
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of SRY-box containing gene 17 correlates with an unfavorable melanoma patient survival.
Lu J; Zhang G; Cheng Y; Tang Y; Dong Z; McElwee KJ; Li G
Oncol Rep; 2014 Dec; 32(6):2571-9. PubMed ID: 25310020
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
Han B; Zhang Q; Li G; Zhang R; Li H
Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
[TBL] [Abstract][Full Text] [Related]
10. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.
Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4.
Tang Y; Cheng Y; Martinka M; Ong CJ; Li G
Carcinogenesis; 2014 Jan; 35(1):86-95. PubMed ID: 24130172
[TBL] [Abstract][Full Text] [Related]
12. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.
Zhou J; Cheng Y; Tang L; Martinka M; Kalia S
Oncotarget; 2017 Mar; 8(12):18712-18725. PubMed ID: 27213583
[TBL] [Abstract][Full Text] [Related]
14. Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma.
Soltani MH; Pichardo R; Song Z; Sangha N; Camacho F; Satyamoorthy K; Sangueza OP; Setaluri V
Am J Pathol; 2005 Jun; 166(6):1841-50. PubMed ID: 15920168
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of neuropilin 1 in melanoma progression and its prognostic significance in patients with melanoma.
Lu J; Cheng Y; Zhang G; Tang Y; Dong Z; McElwee KJ; Li G
Mol Med Rep; 2015 Aug; 12(2):2668-76. PubMed ID: 25954957
[TBL] [Abstract][Full Text] [Related]
16. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression.
Lade-Keller J; Riber-Hansen R; Guldberg P; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Br J Dermatol; 2013 Sep; 169(3):618-28. PubMed ID: 23662813
[TBL] [Abstract][Full Text] [Related]
17. HER3 is a determinant for poor prognosis in melanoma.
Reschke M; Mihic-Probst D; van der Horst EH; Knyazev P; Wild PJ; Hutterer M; Meyer S; Dummer R; Moch H; Ullrich A
Clin Cancer Res; 2008 Aug; 14(16):5188-97. PubMed ID: 18698037
[TBL] [Abstract][Full Text] [Related]
18. Loss of SNF5 expression correlates with poor patient survival in melanoma.
Lin H; Wong RP; Martinka M; Li G
Clin Cancer Res; 2009 Oct; 15(20):6404-11. PubMed ID: 19808872
[TBL] [Abstract][Full Text] [Related]
19. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
20. CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.
Thies A; Moll I; Berger J; Wagener C; Brümmer J; Schulze HJ; Brunner G; Schumacher U
J Clin Oncol; 2002 May; 20(10):2530-6. PubMed ID: 12011132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
